Company Encyclopedia
View More
name
Canature Health
300272.SZ
Canature Health Technology Co., Ltd. engages in the research, development, manufacture, production of residential water treatment products in China, the Middle East, Europe, rest of Asia, North America, and internationally. Its products include whole-house water purifiers and softeners, commercial purified water dispensers, membrane reverse osmosis water purifiers, multi-way control valves, composite material pressure vessels, and membrane elements. The company was formerly known as Shanghai Canature Environmental Products Co., Ltd.
1.645 T
300272.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Household AppliancesIndustry
Industry Ranking43/53
Industry medianC
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE7.05%C
    • Profit Margin5.29%C
    • Gross Margin38.61%B
  • Growth ScoreB
    • Revenue YoY6.29%C
    • Net Profit YoY8.56%C
    • Total Assets YoY6.21%B
    • Net Assets YoY15.43%A
  • Cash ScoreB
    • Cash Flow Margin1889.02%A
    • OCF YoY6.29%C
  • Operating ScoreB
    • Turnover0.57B
  • Debt ScoreC
    • Gearing Ratio51.89%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Canature Health: Plans to acquire part of the subsidiaries of YuanNeng Group to strengthen investment layout in the cell industry

    Canature Health plans to acquire a portion of the subsidiaries of Yuaneng Group, aiming to strengthen its investment layout in the cell industry and create a second growth curve by acquiring all equity and assets related to the cell industry in cash. After the acquisition, Yuaneng Group will retain its core assets and cell storage business and undertake the national project regarding "cell automated manufacturing plants." Canature Health currently holds 43.70% of the shares in Yuaneng Group and will continue to support the development of related industries

    Zhitong·
    SZ
    300272
    -0.40%
    Zhitong·
    SZ
    300272
    -0.40%

    Canature Health: Third quarter net profit of 25.2074 million yuan, a decrease of 7.10%

    Canature Health announced that its revenue for the third quarter was 466 million yuan, a year-on-year increase of 9.80%; net profit was 25.2074 million yuan, a decrease of 7.10%. Revenue for the first three quarters was 1.3556 billion yuan, a year-on-year increase of 8.10%; net profit was 95.3532 million yuan, a year-on-year increase of 13.29%

    Zhitong·
    SZ
    300272
    -0.40%
    Zhitong·
    SZ
    300272
    -0.40%

    Canature Health plans to establish a wholly-owned subsidiary in the cell industry to create a second growth curve

    According to the Zhitong Finance APP, Canature Health announced that the company plans to establish a wholly-owned subsidiary with its own funds in regions such as Hainan Province or Hunan Province to engage in the cell industry business and industry mergers and acquisitions, with a registered capital of 100 million yuan for the wholly-owned subsidiary. The establishment of this wholly-owned subsidiary will strengthen Canature Health's layout in the cell industry, enter the cell industry business and industry mergers and acquisitions, thereby creating the cell industry as the company's second growth curve

    Zhitong·
    SZ
    300272
    -0.40%
    Zhitong·
    SZ
    300272
    -0.40%

    Canature Health establishes a new company including AI-related businesses

    According to the Qichacha APP, recently, Shanghai Qingsen Zhichuang Information Technology Co., Ltd. was established, with Qu Yaming as the legal representative. The business scope includes: information system integration services; intelligent control system integration; artificial intelligence industry application system integration services; technical consulting services for artificial intelligence public service platforms, etc. Qichacha's equity penetration shows that the company is wholly owned by Canature Health indirectly

    Zhitong·
    SZ
    300272
    -0.40%
    Zhitong·
    SZ
    300272
    -0.40%

    Canature Health: Vice Chairman Qu Yaming elected Chairman of Yuan Neng Cell Technology Group

    Canature Health announced that the company recommended Vice Chairman Qu Yaming as a candidate for the first board of directors of Yuan Neng Cell Technology Group, and was approved by the shareholders' meeting. Qu Yaming was elected as the Chairman of Yuan Neng Group. This change complies with relevant laws and regulations as well as the company's articles of association, and will help strengthen the company's post-investment management of Yuan Neng Group, aligning with the interests of the company and all shareholders

    Zhitong·
    SZ
    300272
    -0.40%
    Zhitong·
    SZ
    300272
    -0.40%
    © 2025 Longbridge｜Disclaimer